Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

NCT06016855 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT06016855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Phase 4
Overall status
Recruiting
Start date
May 31, 2024
Completion date
May 28, 2028
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system neuroendocrine tumor g1, digestive system neuroendocrine tumor g2, metastatic digestive system neuroendocrine neoplasm, metastatic malignant neoplasm in the liver, pancreatic neuroendocrine tumor g1, pancreatic neuroendocrine tumor g2